Marshall Wace LLP cut its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 73.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 229,270 shares of the medical research company’s stock after selling 643,025 shares during the period. Marshall Wace LLP owned approximately 0.24% […]